Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion type Assertion NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_head.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion evidence source_evidence_literature NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion SIO_000772 24590266 NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion wasDerivedFrom befree-2016 NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion wasGeneratedBy ECO_0000203 NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.